Andrea Ellis sold $4.2M of BridgeBio Pharma (BBIO)

Executed Mar 4, disclosed Mar 6, 2 days later.

Value, as filed

$4.2M

64,921 sh × $64.87

Executed

Mar 4

the trade date, as filed

Disclosed

Mar 6

2 days after the trade

Return, 21 sessionsiFrom the disclosed entry session; derived

–

purchases only

Returns are measured on stock purchases only.

The filer

Andrea Ellis Director profile →

Andrea Ellis (Director) filed 2 Form 4 reports in the trailing twelve months (0 purchases, 2 sales), most often in BridgeBio Pharma, Inc. (BBIO). The largest single filing was $4.2M of BBIO (64,921 sh × $64.87, as filed), executed Mar 4.

The name

BBIO

BridgeBio Pharma, Inc. BBIO · Healthcare · 71 filings in 24 months ticker →

Healthcare · BridgeBio Pharma, Inc., a biopharmaceutical company, discovers, develops, and delivers medicines for patients with genetic diseases

More Healthcare filings→ Insider filings, newest first→ View the original filing at www.sec.gov→

Other filings by Andrea Ellis in BBIO

BBIOSALE BridgeBio Pharma, Inc. $1.4M
17,167 sh × $84.00
Exec Jul 9
Filed Jul 13 · 4:41 PM ET BBIOSALE BridgeBio Pharma, Inc. $841K
17,167 sh × $49.00
Exec Aug 5 2025
Filed Aug 7 2025 · 5:30 PM ET BBIOSALE BridgeBio Pharma, Inc. $350K
10,000 sh × $35.00
Exec Apr 14 2025
Filed Apr 16 2025 · 5:30 PM ET BBIOSALE BridgeBio Pharma, Inc. $1.0M
30,000 sh × $34.05
Exec Apr 1 2025
Filed Apr 3 2025 · 5:30 PM ET